Threshold Pharmaceuticals Presents Positive Preclinical Results at International Myeloma Workshop
03 mai 2011 16h00 HE
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., May 3, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), today announced a presentation of preclinical research on its clinical stage hypoxia-activated...
Threshold Update Since Sudden Death of Its Chief Medical Officer
25 avr. 2011 08h30 HE
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., April 25, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today provided an update since the death last week of John G. Curd, M.D., president and chief...
Threshold Announces Unexpected Death of Its Chief Medical Officer
21 avr. 2011 08h30 HE
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., April 21, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), today announced the death of John G. Curd, M.D., president and chief medical officer. Dr. Curd...
Threshold Announces Presentation and Webcast at BioCentury Future Leaders Conference
12 avr. 2011 16h00 HE
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., April 12, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced that Dr. Barry Selick, Threshold's chief executive officer, is scheduled to...
Threshold to Present at Needham Healthcare Conference
04 avr. 2011 16h00 HE
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., April 4, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced that Dr. Barry Selick, Threshold's chief executive officer, will present at the...
Threshold Pharmaceuticals Presents TH-302 Translational Data in Three Scientific Presentations at AACR Annual Meeting
04 avr. 2011 08h35 HE
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., April 4, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced multiple preclinical presentations on its clinical stage hypoxia-activated...
Threshold Pharmaceuticals Reports Fourth Quarter and Year End 2010 Financial Results
24 mars 2011 08h35 HE
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., March 24, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), today reported financial results for the fourth quarter and the year ended December 31,...
Threshold Pharmaceuticals Completes $30 Million Registered Direct Offering
17 mars 2011 08h35 HE
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., March 17, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced the completion of its previously announced registered direct offering of common...
Threshold Pharmaceuticals Announces Registered Direct Offering of $30 Million
11 mars 2011 09h21 HE
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., March 11, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), today announced that it has agreed to sell approximately $30 million of its common stock and...
Threshold Pharmaceuticals Announces Agreement With the FDA on a Special Protocol Assessment for Planned Phase 3 TH-302 Combination Trial in Advanced Soft Tissue Sarcoma
16 févr. 2011 08h30 HE
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., Feb. 16, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced that the Company reached agreement with the U.S. Food and Drug Administration...